New virus detection process under development at Rutgers-Camden
On Apr. 21, 2020,the fight against the coronavirus is underway in a Rutgers Universityï¾–Camden research laboratory, where chemistry…
Mammoth Biosciences announced peer-reviewed validation of its rapid, CRISPR-based COVID-19 diagnostic
On Apr. 16, 2020, Mammoth Biosciences announced the publication of a study demonstrating the power of its platform…
Moderna announced BARDA award for up to $483 million to accelerate development of mRNA vaccine (mRNA-1273) against novel Coronavirus
On Apr. 16, 2020, Moderna announced an agreement for a commitment of up to $483 million from the…
The Jackson Laboratory to provide expanded Coronavirus testing for Maine hospitals
On Apr. 14, 2020, the Jackson Laboratory (JAX) in collaboration with several Maine regional hospitals, announced that it…
Blackstone and Alnylam announced $2 billion strategic financing collaboration to accelerate advancement of RNAi therapeutics
On Apr. 13, 2020, Blackstone and Alnylam Pharma announced a broad strategic collaboration under which Blackstone will provide…
Fujifilm announced the start of a phase II clinical trial of its influenza antiviral drug ‘Avigan’ Tablet for COVID-19 patients in the U.S.
On Apr. 9, 2020, FUJIFILM announced initiation of a U.S. phase II clinical trial to evaluate the safety…
New antiviral drug from Emory University heading into clinical trials for COVID-19 treatment
On Apr. 6, 2020, Emory’s Vaccine and Treatment Evaluation Unit (VTEU) announced its participation in a clinical trial…
VGXI established pilot mRNA manufacturing capabilities
On Apr. 6, 2020, VGX announced successful implementation of new RNA production services through completion of all Phase…
Vir and Alnylam expand collaboration to advance investigational RNAi therapeutics targeting host factors fof COVID-19
On Apr. 2, 2020, Vir Biotech and Alnylam Pharma announced an expansion to their broad multi-target existing collaboration…
Fujifilm announced start of phase III clinical trial of influenza antiviral drug ‘Avigan Tablet’ on COVID-19 patients
On Mar. 31, 2020, FUJIFILM announced initiation of a phase III clinical trial to evaluate the safety and…
MatMaCorp’s DNA and RNA testing platform could help protect the U.S. pork supply from African swine fever
On Mar. 24, 2020, MatMaCorp announced the successful evaluation of a genetic test to detect African swine fever…
Pfizer and BioNTech co-develop potential Coronavirus (COVID-19)
On Mar. 17, 2020, Pfizer and BioNTech SE announced the companies have agreed to a letter of intent…
Moderna announced first participant dosed in NIH-led phase 1 study of mRNA vaccine against novel Coronavirus
On Mar. 16, 2020, Moderna announced it has released the first batch of mRNA-1273, the Companyï¾’s vaccine against…
CureVac focuses on development of mRNA-based coronavirus vaccine to protect people worldwide
On Mar. 15, 2020, CureVac announced that internal efforts will be focused on the development of a coronavirus…
Fosun Pharma and BioNTech formed COVID-19 vaccine strategic alliance in China
On Mar. 15, 2020, Fosun Pharma and BioNTech announced a strategic development and commercialization collaboration to advance BioNTech’s…
Quest Diagnostics planned launch for coronavirus disease 2019 (COVID-19) test
On Mar. 5, 2020, Quest Diagnostics announced it will launch a coronavirus (COVID-19) test service. The new test…
Vir Biotec and and Alnylam expanded collaboration to advance RNAi therapeutics for reatment of Coronavirus Infection
On Mar. 4, 2020, Vir Biotech and Alnylam Pharmaceuticals announced an expansion of their existing collaboration to include…
Moderna completed enrollment of Cytomegalovirus vaccine (mRNA-1647) phase 2 study
On Mar. 3, 2020, Moderna announced that enrollment was complete for all three dose cohorts of the Phase…
Moderna shipped mRNA vaccine against novel Coronavirus (mRNA-1273) for phase 1 study
On Feb. 24, 2020, Moderna announced it had released the first batch of mRNA-1273, the Company’s vaccine against…
HDT Bio joined race to develop Coronavirus vaccine
On Feb. 13, 2020, scientists at HDT Bio announced development of a vaccine to protect against the 2019-novel…
Moderna announced funding award from CEPI to accelerate development of mRNA vaccine against novel Coronavirus
On Jan. 23, 2020, Moderna announced a new collaboration to develop an mRNA vaccine against the novel coronavirus…
NIH grant awarded to Georgia Tech researchers to develop mRNA-based drug to correct hematopoietic stem cells
On Oct. 1, 2019, the National Institutes of Health (NIH) awarded a $3.5 million grant to Georgia Institute…
Eleventh U.S. CRISPR-Cas9 Patent Awarded to University of California, U Vienna, Charpentier
On Aug. 20, 2019, the eleventh U.S. CRISPR-Cas9 patent was awarded to University of California, the University of…
Yale professor Joan Steitz awarded the 2018 Lasker~Koshland Special Achievement Award in Medical Science
On Sept. 11, 2018, Joan Steitz, Sterling Professor of Molecular Biophysics and Biochemistry at Yale, received the 2018ï¾ …
Pacific Northwest Diabetes Research Institute received a $2 million grant for RNA research
On Aug. 6, 2013, Pacific Northwest Diabetes Research Institute (PNDRI) received a $2 million National Institutes of Health…
Infectious disease diagnostics was formed on the basis of detailed RNA structure of specific pathogens
In 2012, Harvard scientists led by Deborah Hung showed that a detailed RNA signature of specific pathogens can…
Marina Biotech acquired Cequent Pharmaceuticals for $44 million
On Jul. 22, 2010, MDRNA announced that MDRNA shareholders approved the issuance of shares of MDRNA common stock…
James Carrington, a professor of botany at Oregon State University was elected to the National Academy of Sciences
On Feb. 25, 2008, Oregon State University’s James Carrington, a professor of botany and plant pathology and a…
The CDC received FDA approval for a highly sensitive influenza PCR assay
In 2008, the U.S. Centers for Disease Control and Prevention (CDC) received U.S. Food and Drug Administration (FDA)…
Integrated DNA Technologies acquired Belgian manufacturer and established European operating base in Leuven, Belgium
On Sept. 18, 2006, Integrated DNA Technologies (IDT) announced the acquisition of RNA-TEC, based in Leuven, Belgium. The…